Analyst Recommendations

Guggenheim analyst issues NEUTRAL recommendation for GSK on October 31, 2024 05:02AM ET. The previous analyst recommendation was Buy.GSK was trading at $37.01 at issue of the analyst...

October 31, 2024   GSK 1.32%

CLSA analyst issues OUTPERFORM recommendation for JP on October 31, 2024 12:28AM ET. The previous analyst recommendation was Outperform.JP was trading at $0.38 at issue of the analyst...

October 31, 2024   GSK 1.32%

Santander analyst issues OUTPERFORM recommendation for BRFS on October 30, 2024 09:22PM ET. BRFS was trading at $4.47 at issue of the analyst recommendation.The overall analyst consensus :...

October 30, 2024   BRFS 0.84%

Barclays analyst issues UNDERWEIGHT recommendation for ERIC on October 30, 2024 03:39PM ET. The previous analyst recommendation was Underweight.ERIC was trading at $8.51 at issue of the analyst...

October 30, 2024   ERIC 0.12%

Citigroup analyst issues BUY recommendation for PSO on October 30, 2024 03:14PM ET. The previous analyst recommendation was Buy.PSO was trading at $14.66 at issue of the analyst...

October 30, 2024   PSO 0.43%

Barclays analyst issues UNDERWEIGHT recommendation for NOK on October 30, 2024 03:41PM ET. The previous analyst recommendation was Underweight.NOK was trading at $4.78 at issue of the analyst...

October 30, 2024   NOK 0.00%

Barclays analyst issues EQUAL-WEIGHT recommendation for PSO on October 30, 2024 03:41PM ET. The previous analyst recommendation was Equal-Weight.PSO was trading at $14.66 at issue of the analyst...

October 30, 2024   PSO 0.43%

Santander analyst issues EQUAL-WEIGHT recommendation for SAN on October 30, 2024 01:01PM ET. The previous analyst recommendation was Equal-Weight.SAN was trading at $4.8814 at issue of the analyst...

October 30, 2024   SAN 0.52%

Lake Street analyst issues BUY recommendation for OPRA on October 30, 2024 08:38AM ET. The previous analyst recommendation was Buy.OPRA was trading at $18.2 at issue of the...

October 30, 2024   OPRA -0.11%

Cowen & Co. analyst issues BUY recommendation for OPRA on October 30, 2024 07:36AM ET. The previous analyst recommendation was Buy.OPRA was trading at $18.57 at issue of...

October 30, 2024   OPRA -0.11%